D

Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450

Watchlist Manager
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Watchlist
Price: 17 330 KRW -3.18% Market Closed
Market Cap: 770.5B KRW

Wall Street
Price Targets

Price Targets Summary
Dongkook Pharmaceutical Co Ltd

Wall Street analysts forecast Dongkook Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Dongkook Pharmaceutical Co Ltd is 26 010 KRW with a low forecast of 23 230 KRW and a high forecast of 29 400 KRW.

Lowest
Price Target
23 230 KRW
34% Upside
Average
Price Target
26 010 KRW
50% Upside
Highest
Price Target
29 400 KRW
70% Upside
Dongkook Pharmaceutical Co Ltd Competitors:
Price Targets
4577
Daito Pharmaceutical Co Ltd
4% Downside
JBCHEPHARM
J B Chemicals and Pharmaceuticals Ltd
19% Upside
AZN
AstraZeneca PLC
23% Upside
4506
Sumitomo Pharma Co Ltd
35% Downside
600276
Jiangsu Hengrui Pharmaceuticals Co Ltd
13% Upside
1795
Lotus Pharmaceutical Co Ltd
40% Upside
002399
Shenzhen Hepalink Pharmaceutical Group Co Ltd
40% Downside
600285
Henan Lingrui Pharmaceutical Co Ltd
25% Upside

Revenue
Forecast

Revenue Estimate
Dongkook Pharmaceutical Co Ltd

For the last 11 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's revenue is 13%. The projected CAGR for the next 3 years is 10%.

13%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Dongkook Pharmaceutical Co Ltd

For the last 11 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 16%.

11%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Dongkook Pharmaceutical Co Ltd

For the last 11 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's net income is 12%. The projected CAGR for the next 3 years is 15%.

12%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Dongkook Pharmaceutical Co Ltd's stock price target?
Price Target
26 010 KRW

According to Wall Street analysts, the average 1-year price target for Dongkook Pharmaceutical Co Ltd is 26 010 KRW with a low forecast of 23 230 KRW and a high forecast of 29 400 KRW.

What is Dongkook Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
10%

For the last 11 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's revenue is 13%. The projected CAGR for the next 3 years is 10%.

What is Dongkook Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
16%

For the last 11 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 16%.

What is Dongkook Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
15%

For the last 11 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's net income is 12%. The projected CAGR for the next 3 years is 15%.

Back to Top